Gennex Laboratories Ltd.

16.94 -0.06 ▼-0.4%

08 December 2023, 04:01:00 PM
Volume: 610,205

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gennexlab.com
Market Cap 303.24 Cr.
Enterprise Value(EV) 325.11 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.45 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 37.95 Trailing Twelve Months Ending 2023-09
Industry PE 38.54 Trailing Twelve Months Ending 2023-09
Book Value / Share 4.72 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.59 Calculated using Price: 16.94
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 17.90 Cr. 179,009,534 Shares
FaceValue 1
About Gennex Laboratories Ltd.
Gennex Laboratories (formerly Prudential Pharmaceuticals) is a public limited company established in the year 1995 and has been engaged in the manufacturing of bulk drugs and intermediates. The company started as one of the leading manufacturer and exporter of bulk drugs and intermediates. Quality is the strength of the company and major part of its finished products are exported to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and other major countries. Gennex Laboratories has diversified its activities to biotech products in order to have better prospects and opportunities for the company for expanding its bussiness activities and to meet the marketing requirements.

Gennex Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Gennex Laboratories Ltd. Performance

1 Day
-0.35%
1 Week
+5.41%
1 Month
+40.23%
3 Month
+111.75%
6 Month
+139.94%
1 Year
+180.93%
2 Year
+119.71%
5 Year
+369.25%
10 Year
+2252.78%

Gennex Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.57 8.69 9.14 2.67 6.75 5.32 10.66 9.35 7.43
Return on Capital Employed (%) 4.57 11.78 11.61 6.31 10.49 8.32 13.18 11.78 10.70
Return on Assets (%) 1.66 5.77 5.94 1.68 4.34 3.40 6.95 6.16 5.55

Gennex Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 26 28 31 32 34 36 40 44 79 85
Non Curr. Liab. 1 1 1 1 1 0 0 1 2
Curr. Liab. 13 12 17 18 17 21 19 24 16 18
Minority Int.
Equity & Liab. 39 42 49 50 52 57 59 68 96 104
Non Curr. Assets 22 23 23 23 23 22 23 21 24 24
Curr. Assets 17 19 26 28 29 35 36 47 72 81
Misc. Exp. not W/O
Total Assets 39 42 49 50 52 57 59 68 96 104

Gennex Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 32 39 42 44 56 56 60 61 65 61
Other Income 0 0 0 1 1 1 1 1 3 2
Total Income 32 39 42 45 57 57 60 63 69 63
Total Expenditure -30 -34 -37 -42 -52 -52 -53 -56 -61 -50
PBIDT 2 4 5 3 5 4 7 7 8 13
Interest 0 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 -1 0 -1 -1 -1 -1 -1 -1 -3
Exceptional Items 0 0 0 0
PAT 1 2 3 1 2 2 4 4 5 8
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Gennex Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 3 0 3 2 -2 -1 7 -14
Cash Fr. Inv. -1 0 -1 -1 -1 -1 0 0 -1 -1
Cash Fr. Finan. 0 0 -2 1 -2 1 0 2 2 21
Net Change 0 0 0 0 0 2 -2 0 7 6
Cash & Cash Eqvt 0 1 1 1 1 3 1 1 8 14

Gennex Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 22.05 22.05 22.05 22.05 23.38 23.38 23.38 23.38 23.60
Public 77.95 77.95 77.95 77.95 76.62 76.62 76.62 76.62 76.40
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 8.07 8.07 8.07 8.84 3.46 3.46 34.17 34.14

Gennex Laboratories Ltd. Announcements

Mon, 04 Dec 2023
EGM Of Gennex Laboratories Limited - BSE Script Code: 531739
Pursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from 24.12.2023 to 30.12.2023 (both days inclusive) for the purpose of EGM to be held on Saturday 30.12.2023 to seek the approval of the shareholders of the Company inter alia in relation to:1. Increase in authorised share capital from Rs. 20 Crore to 25 Crore.2. Issuance of upto 5 00 00 000 equity shares of the Company having face value of Re.1/- each on preferential basis to specified persons.3. Issuance of upto 1 55 00 000 share warrants of the Company to the promoters and members of the promoter group on a preferential basis.The intimation is also being uploaded on the Company website: www.gennexlab.comWe request you to take the above information on record and acknowledge the receipt of the same.
Mon, 04 Dec 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for JMS Mining Pvt Ltd
Sat, 02 Dec 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On December 02 2023
Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015 in furtherance to our intimation dated 20/11/2023 and 29/11/2023 we wish to inform you that Board of Directors of the Company at its meeting held today on 02/12/2023 has considered and approved the following:1. To increase the authorised share capital of the Company from Rs. 20 Crore to Rs. 25 Crore and consequential alteration in Clause V of the MOA and Clause 4(i) of the AOA of the Company subject to approval of the shareholders of the Company.2. Issuance of upto 5 00 00 000 equity shares of the Company having face value of Rs. 1/- each on preferential basis to specified persons3. Issuance of upto 1 55 00 000 share warrants of the Company to the promoters and members of promoter group on a preferential basis4. Calling of Extraordinary General Meeting5. Book Closure for ensuing EGM and record date/ cut-off date for e-voting.The meeting commenced at 2:00 pm and concluded at 4:00 pm.

Gennex Laboratories Ltd. Technical Scans

Fri, 08 Dec 2023
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High

Gennex Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,403.90 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,685.46 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,584.38 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.50 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.25 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.16 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.96 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.37 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Gennex Laboratories Ltd. FAQ's

What is Gennex Lab share price?

Can I buy Gennex Lab shares now?

What is the Market Cap of Gennex Lab?

What are the key metrics to analyse Gennex Lab?

What is the 52 Week High and Low of Gennex Lab?

What is the trend of Gennex Lab share price?